Treatment of Orthostatic Hypotension in SCI
ConditionHypotension
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-60
SponsorJames J. Peters Veterans Affairs Medical Center
About this trial
The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.
Eligibility criteria
Qualifiers
traumatic spinal cord injury
at least 12 months post injury
injury level of C1-T6
AIS A, B or C
Disqualifiers
Active psychiatric disorder
Stroke or cerebrovascular disease
Alzheimer's Disease or dementia
Unmanaged cardiac arrhythmias
Trial design
Treatments tested in this trial
- Midodrine Hydrochloride
Treatment groups
25 Participants
are divided into 2 treatment groupsSponsors and collaborators
James J. Peters Veterans Affairs Medical Center
Lead sponsor
Kessler Foundation
Collaborator
Source ClinicalTrials.gov